References1 Wickens, M, Anderson, P, Jackson, RJ. Life and death in the cytoplasm: messages from the 3 ′ end. Curr Opin Genet Dev 1997, 7:220–232. 2 Jacobson, A, Peltz, SW. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Ann Rev Biochem 1996, 65:693. 3 Garneau, NL, Wilusz, J, Wilusz, CJ. The highways and byways of mRNA decay. Nat Rev Mol Cell Biol 2007, 8:113–126. 4 Colgan, DF, Manley, JL. Mechanism and regulation of mRNA polyadenylation. Genes Dev 1997, 11:2755–2766. 5 Zhao, J, Hyman, L, Moore, C. Formation of mRNA 3 ′ ends in eukaryotes: mechanism, regulation and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 1999, 63:405–445. 6 Edmonds, M. A history of poly(A) sequences: from formation to factors to function. Prog Nucleic Acids Res Mol Biol 2002, 71:285–389. 7 Millevoi, S, Vagner, S. Molecular mechanisms of eukaryotic pre‐mRNA 3 ′ end processing regulation. Nucleic Acids Res 2010, 38:2757. 8 Maniatis, T, Reed, R. An extensive network of coupling among gene expression machines. Nature 2002, 416:499–506. 9 Proudfoot, NJ, Furger, A, Dye, MJ. Integrating mRNA processing with transcription. Cell 2002, 108:501–512. 10 Moore, MJ, Proudfoot, NJ. Pre‐mRNA processing reaches back to transcription and ahead to translation. Cell 2009, 136:688–700. 11 Licatalosi, DD, Darnell, RB. RNA processing and its regulation: global insights into biological networks. Nat Rev Genet 2010, 11:75–87. 12 Tian, B, Hu, H, Zhang, H, Lutz, CS. A large‐scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res 2005, 33:201–212. 13 Moreira, A, Wollerton, M, Monks, J, Proudfoot, NJ. Upstream sequence elements enhance poly(A) site efficiency of the C2 complement gene and are phylogenetically conserved. EMBO J 1995, 14:3809–3819. 14 Moreira, A, Takagaki, Y, Brackenridge, S, Wollerton, M, Manley, JL, Proudfoot, NJ. The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3 ′ end formation by two distinct mechanisms. Genes Dev 1998, 12:2522–2534. 15 Lutz, CS, Alwine, JC. Direct interaction of the U1snRNP‐A protein with the upstream efficiency element of the SV40 late polyadenylation signal. Genes Dev 1994, 8:576–586. 16 Chen, F, Wilusz, J. Auxiliary downstream elements are required for efficient polyadenylation of mammalian pre‐mRNAs. Nucleic Acids Res 1998, 26:2891–2898. 17 Bagga, PS, Ford, LP, Chen, F, Wilusz, J. The G‐rich auxiliary downstream element has distinct sequence and position requirements and mediates efficient 3 ′ end and pre‐mRNA processing through a trans‐acting factor. Nucleic Acids Res 1995, 23:1625–1631. 18 Natalizio, BJ, Muniz, LC, Arhin, GK, Wilusz, J, Lutz, CS. Upstream elements present in the 3 ′ untranslated region of collagen genes influence the processing efficiency of overlapping polyadenylation signals. J Biol Chem 2002, 277:42733–42740. 19 Castelo‐Branco, P, Furger, A, Wollerton, M, Smith, C, Moreira, A, Proudfoot, N. Polypyrimidine tract binding protein modulates efficiency of polyadenylation. Mol Cell Biol 2004, 24:4174. 20 Hall‐Pogar, T, Zhang, H, Tian, B, Lutz, CS. Alternative polyadenylation of cyclooxygenase‐2. Nucleic Acids Res 2005, 33:2565–2579. 21 Hall‐Pogar, T, Liang, S, Hague, LK, Lutz, CS. Specific trans‐acting proteins interact with auxiliary RNA polyadenylation elements in the COX‐2 3 ′ UTR. RNA 2007, 13:1103. 22 Hu, J, Lutz, CS, Wilusz, J, Tian, B. Bioinformatic identification of candidate cis‐regulatory elements involved in human mRNA polyadenylation. RNA 2005, 11:1485–1493. 23 Mandel, CR, Bai, Y, Tong, L. Protein factors in pre‐mRNA processing. Cell Mol Life Sci 2008, 65:1099–1122. 24 Shi, Y, Di Giammartino, DC, Taylor, D, Sarkeshik, A, Rice, WJ, Yates, JR III, Frank, J, Manley, JL. Molecular architecture of the human pre‐mRNA 3 ′ processing complex. Mol Cell 2009, 33:365–376. 25 Xing, D, Li, QQ. Alternative polyadenylation. Plant Signal Behav 2009, 4:440–442. 26 Lutz, CS. Alternative polyadenylation: a twist on 3 ′ end formation. ACS Chem Biol 2008, 3:609–617. 27 Ji, Z, Lee, JY, Pan, Z, Jiang, B, Tian, B. Progressive lengthening of 3 ′ untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proc Natl Acad Sci USA 2009, 106:7028–7033. 28 Legendre, M, Ritchie, W, Lopez, F, Gautheret, D. Differential repression of alternative transcripts: a screen for miRNA targets. PLoS Comput Biol 2006, 2:0333–0342. 29 Sandberg, R, Neilson, JR, Sarma, A, Sharp, PA, Burge, CB. Science 2008, 320:1643–1647. 30 Liu, D, Brockman, JM, Dass, B, Hutchins, LN, Singh, P, McCarrey, JR, MacDonald, CC, Graber, JH. Systematic variation in mRNA 3 ′‐processing signals during mouse spermatogenesis. Nucleic Acids Res 2007, 35:234. 31 Mayr, C, Bartel, DP. Widespread shortening of 3 ′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009, 138:673. 32 Evsikov, AV, Graber, JH, Brockman, JM, Hampl, A, Holbrook, AE, Singh, P, Eppig, JJ, Solter, D, Knowles, BB. Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo. Genes Dev 2006, 20:2713. 33 Zhang, H, Lee, JY, Tian, B. Biased alternative polyadenylation in human tissues. Genome Biol 2005, 6:R100. 34 Ji, Z, Tian, B. Reprogramming of 3 ′ untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types. PLoS One 2009, 4:e8419. 35 Coleman, MS, Hutton, JJ, Bollum, FJ. Terminal riboadenylate transferase in human lymphocytes. Nature 1974, 248:407–409. 36 Hauser, H, Knippers, R, Schafer, KP. Increased rate for RNA‐polyadenylation. An early response in Concanavalin A activated lymphocytes. Exp Cell Res 1978, 111:175–184. 37 Edwalds‐Gilbert, G, Veraldi, K, Milcarek, C. Alternative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Res 1998, 25:2547. 38 Chuvpilo, S, Zimmer, M, Kerstan, A, Glöckner, J, Avots, A, Escher, C, Fischer, C, Inashkina, I, Jankevics, E, Berberich‐Siebelt, F, et al. Alternative polyadenylation events contribute to the induction of NF‐ATc in effector T cells. Immunity 1999, 10:261. 39 Lee, YS, Dutta, A. The tumor suppressor microRNA let‐7 represses the HMGA2 oncogene. Genes Dev 2007, 21:1025. 40 Mayr, C, Hemann, MT, Bartel, DP. Disrupting the pairing between let‐7 and Hmga2 enhances oncogenic transformation. Science 2007, 315:5818. 41 Wiestner, A, Tehrani, M, Chiorazzi, M, Wright, G, Gibellini, F, Nakayama, K, Liu, H, Rosenwald, A, Muller‐Hermelink, HK, Ott, G, et al. Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood 2007, 109:4599. 42 Singh, P, Alley, TL, Wright, SM, Kamdar, S, Schott, W, Wilpan, RY, Mills, KD, Graber, JH. Global changes in processing of mRNA 3 ′ untranslated regions characterize clinically distinct cancer subtypes. Cancer Res 2009, 69:9422. 43 Martincic, K, Alkan, SA, Cheatle, A, Borghesi, L, Milcarek, C. Transcription elongation factor ELL2 directs immunoglobulin secretion in plasma cells by stimulating altered RNA processing. Nat Immunol 2009, 10:1102. 44 Danckwardt, S, Kaufmann, I, Gentzel, M, Foerstner, KU, Gantzert, AS, Gehring, NH, Neu‐Yilik, G, Bork, P, Keller, W, Wilm, M, et al. Splicing factors stimulate polyadenylation via USEs at non‐canonical 3 ′ end formation signals. EMBO J 2007, 26:2658. 45 Melton, AA, Jackson, J, Wang, J, Lynch, KW. Combinatorial control of signal‐induced exon repression by hnRNP L and PSF. Mol Cell Biol 2007, 19:6972. 46 Newnham, CM, Hall‐Pogar, T, Liang, S, Tian, B, Hu, J, Lutz, CS. Alternative polyadenylation of MeCP2: influence of cis‐acting elements and trans‐acting factors. RNA Biol 2010, 7:361. 47 Licatalosi, DD, Mele, A, Fak, JJ, Ule, J, Kayikci, M, Chi, SW, Clark, TA, Schweitzer, AC, Blume, JE, Wang, X, et al. HITS‐CLIP yields genome‐wide insights into brain alternative RNA processing. Nature 2008, 456:464. 48 Takagaki, Y, Seipelt, RL, Peterson, ML, Manley, JL. The polyadenylation factor CstF‐64 regulates alternative processing of IgM heavy chain pre‐mRNA during B cell differentiation. Cell 1996, 87:941. 49 Salisbury, J, Hutchison, KW, Wigglesworth, K, Eppig, JJ, Graber, JH. Probe‐level analysis of expression microarrays characterizes isoform‐specific degradation during mouse oocyte maturation. PLoS One 2009, 4:e7479. 50 Ramskold, D, Wang, ET, Burge, CB, Sandberg, R. An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput Biol 2009, 5:e1000598. 51 Llamazares, S, Moreira, A, Tavares, A, Girdham, C, Spruce, BA, Gonzalez, C, Karess, RE, Glover, DM, Sunkel, CE. Polo encodes a protein kinase homolog required for mitosis in Drosophila. Genes Dev 1991, 5:2153–2156. 52 Moreira, A, Pinto, P, Sunkel, C, Carmo, A. Upstream sequence elements are required for mRNA 3 ′‐end formation of the Drosophila melanogaster cell cycle POLO kinase. FASEB J 2005, 19:A87. 53 Mitchelson, A, Simonelig, M, Williams, C, O`Hare, K. Homology with Saccharomyces cerevisiae RNA14 suggests that phenotypic suppression in Drosophila melanogaster by suppressor of forked occurs at the level of RNA stability. Genes Dev 1993, 7:241. 54 Takagaki, Y, Manley, JL. A polyadenylation factor subunit is the human homologue of the Drosophila suppressor of forked protein. Nature 1994, 372:471. 55 Frischmeyer, PA, van Hoof, A, O`Donnell, K, Guerrerio, AL, Parker, R, Dietz, HC. An mRNA surveillance mechanism that eliminates transcripts lacking termination codons. Science 2002, 295:2258. 56 Audibert, A, Simonelig, M. Autoregulation at the level of mRNA 3 ′ end formation of the suppressor of forked gene of Drosophila melanogaster is conserved in Drosophila virilis. Proc Natl Acad Sci USA 1998, 95:14302. 57 Juge, F, Audibert, A, Benoit, B, Simonelig, M. Tissue‐specific autoregulation of Drosophila suppressor of forked by alternative poly(A) site utilization leads to accumulation of the suppressor of forked protein in mitotically active cells. RNA 2000, 6:1529. 58 Takagaki, Y, Manley, JL. Complex protein interactions within the human polyadenylation machinery identify a novel component. Mol Cell Biol 2000, 20:1515. 59 Pan, Z, Zhang, H, Hague, LK, Lee, JY, Lutz, CS, Tian, B. An intronic polyadenylation site in human and mouse CstF‐77 genes suggests an evolutionarily conserved regulatory mechanism. Gene 2006, 366:325. 60 Wojcik, E, Murphy, AM, Fares, H, Dang‐Vu, K, Tsubota, SI. Enhancer of rudimentaryp1, e(r)p1, a highly conserved enhancer of the rudimentary gene. Genetics 1994, 138:1163 . 61 Gawande, B, Robida, MD, Rahn, A, Singh, R. Drosophila sex‐lethal protein mediates polyadenylation switching in the female germline. EMBO J 2006, 25:1263. 62 Wood, AJ, Schulz, R, Woodfine, K, Koltowska, K, Beechey, CV, Peters, J, Bourc`his, D, Oakey, RJ. Regulation of alternative polyadenylation by genomic imprinting. Genes Dev 2008, 22:1141. 63 Spies, N, Nielsen, CB, Padgett, RA, Burge, CB. Biased chromatin signatures around polyadenylation sites and exons. Mol Cell 2009, 36:245. 64 Lian, Z, Karpikov, A, Lian, J, Mahajan, MC, Hartman, S, Gerstein, M, Snyder, M, Weissman, SM. A genomic analysis of RNA polymerase II modification and chromatin architecture related to 3 ′ end RNA polyadenylation. Genome Res 2008, 18:1224. 65 Martinicic, K, Campbell, R, Edwalds‐Gilbert, G, Souan, L, Lotze, M. Increase in 64 Kilodalton subunit of the cleavage and polyadenylation stimulatory factor during G0 to S phase transition. Proc Natl Acad Sci USA 1998, 95:11095–11100. 66 Veraldi, KL, Arhin, GK, Martincic, K, Chung‐Ganster, LH, Wilusz, J, Milcarek, C. hnRNP F influences binding of a 64‐kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B cells. Mol Cell Biol 2001, 21:1228. 67 Wallace, AM, Denison, TL, Attaya, EN, MacDonald, CC. Developmental distribution of the polyadenylation protein CstF‐64 and the variant tauCstF‐64 in mouse and rat testis. Biol Reprod 2004, 70:1080. 68 Shankarling, GS, Coates, PW, Dass, B, MacDonald, CC. A family of splice variants of CstF‐64 expressed in vertebrate nervous systems. BMC Mol Biol 2009, 10:22. 69 Al‐Ahmadi, W, Al‐Ghamdi, M, Al‐Haj, L, Al‐Saif, M, Khabar, KS. Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU‐rich elements and auto‐regulation. Nucleic Acids Res 2009, 37:3612. 70 Ford, LP, Watson, J, Keene, JD, Wilusz, J. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev 1999, 15:188. 71 Zhu, H, Zhou, HL, Hasman, RA, Lou, H. Hu proteins regulate polyadenylation by blocking sites containing U‐rich sequences. J Biol Chem 2007, 282:2203.